Literature DB >> 7568229

APX-1 can substitute for its homolog LAG-2 to direct cell interactions throughout Caenorhabditis elegans development.

D Gao1, J Kimble.   

Abstract

The homologous LAG-2 and APX-1 membrane proteins are putative signaling ligands in the GLP-1/LIN-12 signal-transduction pathway in Caenorhabditis elegans. Normally, LAG-2 and APX-1 mediate distinct cell interactions. Here, we demonstrate that APX-1, which normally interacts with GLP-1 in the early embryo, can substitute for LAG-2 throughout development. When expressed under control of the lag-2 promoter, an apx-1 cDNA can completely rescue a lag-2 null mutant. To substitute for LAG-2, APX-1 must be able to interact with both GLP-1 and LIN-12 receptors and to mediate a variety of cell interactions during development. Therefore, APX-1 and LAG-2 are essentially equivalent in their ability to influence receptor activity. On the basis of this result, we suggest that the existence of multiple-signaling ligands in the LIN-12/GLP-1 signal transduction pathway does not reflect the evolution of functionally distinct proteins but rather the imposition of distinct controls of gene expression upon functionally similar proteins. Finally, we propose that the specification of distinct cell fates by the LIN-12/GLP-1 signal-transduction pathway relies on activities functioning downstream of the ligand and receptor, rather than on specific ligand-receptor interactions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568229      PMCID: PMC40898          DOI: 10.1073/pnas.92.21.9839

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  Making a difference: the role of cell-cell interactions in establishing separate identities for equivalent cells.

Authors:  I Greenwald; G M Rubin
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

Review 2.  Genetic control of cell interactions in nematode development.

Authors:  E J Lambie; J Kimble
Journal:  Annu Rev Genet       Date:  1991       Impact factor: 16.830

3.  Carboxy-terminal truncation activates glp-1 protein to specify vulval fates in Caenorhabditis elegans.

Authors:  S E Mango; E M Maine; J Kimble
Journal:  Nature       Date:  1991-08-29       Impact factor: 49.962

4.  On the control of germ cell development in Caenorhabditis elegans.

Authors:  J E Kimble; J G White
Journal:  Dev Biol       Date:  1981-01-30       Impact factor: 3.582

5.  mRNA surveillance by the Caenorhabditis elegans smg genes.

Authors:  R Pulak; P Anderson
Journal:  Genes Dev       Date:  1993-10       Impact factor: 11.361

6.  Control of cell fate in C. elegans by a GLP-1 peptide consisting primarily of ankyrin repeats.

Authors:  H Roehl; J Kimble
Journal:  Nature       Date:  1993-08-12       Impact factor: 49.962

7.  Sequence of C. elegans lag-2 reveals a cell-signalling domain shared with Delta and Serrate of Drosophila.

Authors:  F E Tax; J J Yeargers; J H Thomas
Journal:  Nature       Date:  1994-03-10       Impact factor: 49.962

8.  Two homologous regulatory genes, lin-12 and glp-1, have overlapping functions.

Authors:  E J Lambie; J Kimble
Journal:  Development       Date:  1991-05       Impact factor: 6.868

9.  glp-1 can substitute for lin-12 in specifying cell fate decisions in Caenorhabditis elegans.

Authors:  K Fitzgerald; H A Wilkinson; I Greenwald
Journal:  Development       Date:  1993-12       Impact factor: 6.868

10.  Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences.

Authors:  C C Mello; J M Kramer; D Stinchcomb; V Ambros
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  14 in total

Review 1.  Ovarian germline stem cells: an unlimited source of oocytes?

Authors:  Carol B Hanna; Jon D Hennebold
Journal:  Fertil Steril       Date:  2014-01       Impact factor: 7.329

2.  Specificity of PS integrin function during embryogenesis resides in the alpha subunit extracellular domain.

Authors:  M D Martin-Bermudo; O M Dunin-Borkowski; N H Brown
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

3.  Functional domains of LAG-2, a putative signaling ligand for LIN-12 and GLP-1 receptors in Caenorhabditis elegans.

Authors:  S T Henderson; D Gao; S Christensen; J Kimble
Journal:  Mol Biol Cell       Date:  1997-09       Impact factor: 4.138

4.  Ectopic Germ Cells Can Induce Niche-like Enwrapment by Neighboring Body Wall Muscle.

Authors:  Kacy L Gordon; Sara G Payne; Lara M Linden-High; Ariel M Pani; Bob Goldstein; E Jane Albert Hubbard; David R Sherwood
Journal:  Curr Biol       Date:  2019-02-21       Impact factor: 10.834

5.  Genetic analysis of Caenorhabditis elegans glp-1 mutants suggests receptor interaction or competition.

Authors:  Anita S-R Pepper; Darrell J Killian; E Jane Albert Hubbard
Journal:  Genetics       Date:  2003-01       Impact factor: 4.562

6.  Dorsoventral patterning of the C. elegans postembryonic mesoderm requires both LIN-12/Notch and TGFbeta signaling.

Authors:  Marisa L Foehr; Jun Liu
Journal:  Dev Biol       Date:  2007-10-25       Impact factor: 3.582

7.  A role of the LIN-12/Notch signaling pathway in diversifying the non-striated egg-laying muscles in C. elegans.

Authors:  Jared J Hale; Nirav M Amin; Carolyn George; Zachary Via; Herong Shi; Jun Liu
Journal:  Dev Biol       Date:  2014-02-07       Impact factor: 3.582

8.  Identification of a novel ADAMTS9/GON-1 function for protein transport from the ER to the Golgi.

Authors:  Sawako Yoshina; Kenjiro Sakaki; Aki Yonezumi-Hayashi; Keiko Gengyo-Ando; Hideshi Inoue; Yuichi Iino; Shohei Mitani
Journal:  Mol Biol Cell       Date:  2012-03-14       Impact factor: 4.138

9.  C. elegans rrf-1 mutations maintain RNAi efficiency in the soma in addition to the germline.

Authors:  Caroline Kumsta; Malene Hansen
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

10.  Function of the PHA-4/FOXA transcription factor during C. elegans post-embryonic development.

Authors:  Di Chen; Donald L Riddle
Journal:  BMC Dev Biol       Date:  2008-02-29       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.